Non-autonomous Cell Proliferation Regulation by Endothelial PAK2
CSEF · 2017 Biochemistry/ Molecular Biology
Overview
Objectives/Goals The objective of this study was to identify a soluble growth factor secreted by endothelial cells, expression of which is normally suppressed by the presence of vascular endothelial PAK2, and which increases in amount when the Pak2 gene is deleted in mouse endothelial cells. Methods/Materials A dot-blot growth factor-targeted antibody array was probed with conditioned medium from endothelial cells (EC) isolated from endothelial-specific Pak2 deletion and wild-type mouse brains and lungs. Medium is conditioned by exposure to cultured cells for 24 hours to accumulate secreted factors. Blots were developed to assess changes in amounts of twenty-four types of growth factors known to influence EC growth in angiogenesis. Finally, a Millipore Scepter automated cell counter was used to perform cell growth/proliferation assays of suspended live cells. Results Dot-blot growth factor matrix analysis of angiogenesis-related factors indicated that in endothelial cells having deleted Pak2, there was a significant increase in production of one soluble angiogenic cytokine factor: interleukin-6 (IL-6). This was also accompanied by significant decrease in synthesis of multiple factors, including Eotaxin1, GM-CSF, IFNgamma, IL13, IL9, TIMP2, TNFA, THPO, and VEGF. Conclusions/Discussion Identifying endothelial Pak2-related changes of angiogenic growth factors supports our hypothesis by providing a mechanistic basis for differences in both endothelial and total cellular proliferation observed in mice having deleted endothelial Pak2. The increase of soluble IL-6 when Pak2 is deleted in endothelial cells is persuasive as the source of total cell proliferation, based on known characteristics of IL-6. These data suggest that natural mutations in vascular cell Pak2 may produce proliferative pathologies in humans.
Summary statement
I identified that the souble growth factor interleukin-6 is secreted by endotheial cells and normally suppressed by PAK2, and increases in amount when the PAK2 gene is deleted in endothelial cells.
Help received
I carried out the project in the lab of Dr. Rebecca Stockton of LABiomed. Dr. Stockton provided me with use of her facilities and resources, and her guidance. Taline Shishonian also provided guidance and supervision.
Competition history
- CSEF 2017
Resources
Related projects
CSEF · 2016
Effects on Mouse Growth of Postnatal Novel Protein Kinase Gene Deletion in Endothelial Cells
ISEF · 2017
Understanding the Proteins Involved in Regenerative Angiogenesis
ISEF · 2015
Contact Dependency of Immune Cells and Endothelial Cells in Promoting Angiogenesis
ISEF · 2021
Assessing the Expression of Angiogenesis-Related Receptors in Endothelial Cell RNA
ISEF · 2025
Investigating the Synergistic Role of IL-1BETA and TGF-BETA in Endothelial-to- Mesenchymal Transition in Coronary Artery Disease
ISEF · 2020
Expression of c-MYC in Human Endothelial Cells Results in Abnormal Vascular Morphogenesis and Metabolic Reprogramming
ISEF · 2026
The Role of VEGF and FGF21 in Restoring the Hypotrophic Response of Endostatin in Neonatal Rat Ventricular Myocytes
ISEF · 2014
Effects of THP-1 Macrophage Conditioned Media on the Growth of Human Umbilical Vein Endothelial Cells
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects